FoundersInvestorsMediaCareersContact
Home / Portfolio / Medka Dx

AI and automation · Originate

Medka Dx

AI-assisted clinical diagnostics, with a flagship autism screening module for children.

StageOriginate
CategoryAI and automation
ModelHomegrown

About the company

Medka Dx is a homegrown Saudi company building AI-assisted diagnostic support for clinicians, with a flagship application in early autism screening. The company won the Healthon Hackathon in 2025.

The solution

The platform applies artificial intelligence to clinical data to support physicians during diagnosis and treatment planning — identifying disease earlier, reducing diagnostic uncertainty and easing the documentation burden that consumes clinical time.

Its flagship module, MEDKA Dx, screens for autism spectrum disorder in children aged 18 to 72 months using caregiver questionnaires, home video analysis, physician input and machine learning. Autism screening in the Kingdom can take weeks to reach an appointment and far longer to reach a diagnosis — during precisely the developmental window in which intervention is most effective. The platform is designed to compress that timeline substantially.

What the KaRama VS team is doing

  • Founded and incorporated the company within the Studio.
  • Entered the company into independent competitions, where it won the Healthon Hackathon.
  • Planning the clinical validation program required to support diagnostic claims.
  • Mapping the SFDA pathway for AI-based clinical decision support.
  • Preparing business plan, financial model and investor materials, and leading capital formation.

Sign up for the studio letter

Quarterly, from Riyadh: what we incorporated, what cleared the SFDA, and what is opening to outside capital.

Sign up